08/13/2024 3:17 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 3:13 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 12:34 PM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 8:15 AM | Charles River Laboratories International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024 6:21 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 3:46 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 3:17 PM | Charles River Laboratories International (Issuer) Pease Flavia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/03/2024 3:37 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 7:05 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 7:18 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 6:56 PM | Charles River Laboratories International (Issuer) Pease Flavia (Reporting)
| Form 4/A | |
05/30/2024 7:02 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4/A | |
05/30/2024 6:47 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4/A | |
05/30/2024 5:58 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:51 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:46 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:48 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:34 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:38 PM | Charles River Laboratories International (Issuer) Pease Flavia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:08 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:10 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4/A | |
05/29/2024 3:05 PM | Charles River Laboratories International (Filer)
| Form SD Specialized Disclosure Report | |
05/28/2024 4:42 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 4:25 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 4:29 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 4:32 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 3:35 PM | Charles River Laboratories International (Issuer) MASSARO GEORGE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 6:24 PM | Andrews Nancy C (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 6:30 PM | Charles River Laboratories International (Issuer) WILSON VIRGINIA M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 4:47 PM | Charles River Laboratories International (Issuer) Thompson Craig B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 4:52 PM | Charles River Laboratories International (Issuer) MACKAY MARTIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 4:38 PM | BERTOLINI ROBERT J (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 4:42 PM | Charles River Laboratories International (Issuer) WALLMAN RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 4:27 PM | Charles River Laboratories International (Issuer) MASSARO GEORGE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 4:30 PM | Charles River Laboratories International (Issuer) Llado George Sr. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 4:34 PM | Charles River Laboratories International (Issuer) Kemps-Polanco Reshema (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 3:49 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 10:30 AM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024 3:20 PM | Charles River Laboratories International (Filer)
| Form S-3ASR | |
05/09/2024 8:17 AM | Charles River Laboratories International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 6:31 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |
04/24/2024 6:30 AM | Charles River Laboratories International (Filer)
| Form DEFA14A | |
03/29/2024 7:00 AM | Charles River Laboratories International (Filer)
| Form DEF 14A | |
03/29/2024 7:01 AM | Charles River Laboratories International (Filer)
| Form ARS | |
03/25/2024 5:48 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4/A | |
03/25/2024 5:52 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4/A | |
03/25/2024 5:58 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4/A | |
03/25/2024 6:00 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4/A | |
03/25/2024 4:49 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4/A | |
03/25/2024 4:52 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4/A | |
03/25/2024 4:55 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4/A | |
03/11/2024 3:42 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 1:34 PM | Charles River Laboratories International (Subject) Knell Michael Gunnar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 3:54 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 11:47 AM | Charles River Laboratories International (Subject) Knell Michael Gunnar (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:37 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 2:14 PM | Charles River Laboratories International (Subject) Creamer Victoria L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 11:42 AM | Charles River Laboratories International (Subject) Parisotto Shannon M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 3:57 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 10:09 AM | Barbo William D (Reporting) Charles River Laboratories International (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 4:28 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:32 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 5:37 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 10:02 AM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 8:19 AM | Charles River Laboratories International (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 7:31 PM | Charles River Laboratories International (Issuer) Kemps-Polanco Reshema (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:35 PM | Charles River Laboratories International (Issuer) Parisotto Shannon M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:14 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:34 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4/A | |
01/31/2024 4:26 PM | Charles River Laboratories International (Issuer) Creamer Victoria L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:28 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:31 PM | Charles River Laboratories International (Issuer) Knell Michael Gunnar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:23 PM | Barbo William D (Reporting) Charles River Laboratories International (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:59 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:03 PM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 3:34 PM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Charles River Laboratories International (Subject)
| Form SC 13G/A | |
01/16/2024 3:32 PM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/11/2024 3:09 PM | Charles River Laboratories International (Issuer) Girshick Birgit (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:10 PM | Charles River Laboratories International (Subject) Creamer Victoria L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:10 PM | Charles River Laboratories International (Issuer) LaPlume Joseph W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 11:36 AM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023 8:23 AM | Charles River Laboratories International (Issuer) FOSTER JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 7:31 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 11:14 AM | Charles River Laboratories International (Subject) LaPlume Joseph W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 8:06 AM | Charles River Laboratories International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 6:30 AM | Charles River Laboratories International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |